048410 - Hyundai Bioscience Co., Ltd.

048410 Summary

Chemicals

Stock Price & Overview

₩6,210 +160 (+2.64%) Close · Sep 4, 2026 KST

KOSDAQ | ₩KRW | Close: ₩6,210 ≈ US$4 · Market cap ₩0.6tn (≈ $428m)

048410 Financial Statements

Breakdown ₩ bn	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015
Total Revenue	3.5	15.1	9.5	7.9	9.2	12.5	30.1	31.2	32.0	36.1	40.7
Cost of Revenue	3.3	3.2	4.4	5.2	5.7	5.9	16.0	16.9	17.1	24.1	28.5
Gross Profit	0.2	11.9	5.0	2.7	3.5	6.6	14.1	14.3	14.8	12.0	12.2
Selling, General & Administrative	18.4	11.0	14.8	29.0	13.3	11.1	11.6	12.3	13.4	19.0	10.8
Operating Income	-18.2	0.8	-9.8	-26.4	-9.8	-4.5	2.6	2.1	1.5	-7.0	1.4
Finance Income	3.6	0.4	0.8	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.1
Finance Costs	2.7	2.3	0.3	0.4	3.0	1.1	0.8	1.0	1.7	1.5	0.4
Pretax Income	-22.1	-6.9	-14.5	-16.6	-19.8	-7.9	1.3	3.3	1.2	-8.1	0.9
Income Tax Expense	0.0	0.0	-0.0	0.8	-0.2	-0.3	0.1	0.2	-0.0	-0.1	0.2
Net Income	-22.1	-6.9	-14.5	-15.8	-20.1	-8.3	0.8	2.6	1.2	-8.1	0.7
Total Comprehensive Income	-22.2	-6.7	-14.5	-15.7	-20.1	-8.3	0.7	2.7	1.3	-7.8	0.7
Interest Income	—	—	—	—	—	—	0.1	0.2	0.1	0.2	0.1
Interest Expense	—	—	—	—	—	—	0.8	1.0	1.7	1.5	0.4

Breakdown ₩ bn	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015
Total Assets	130.7	67.7	52.8	67.3	80.5	93.7	63.2	54.0	49.5	53.4	43.4
Current Assets	44.0	6.8	15.2	24.0	34.9	41.9	33.3	35.7	36.4	37.7	34.1
Cash & Cash Equivalents	22.3	3.7	1.8	2.7	9.2	19.2	5.6	3.2	4.9	9.7	11.9
Inventories	1.1	1.1	2.6	2.9	3.3	4.2	6.1	4.2	5.9	6.7	5.5
Trade Receivables	2.5	1.6	0.5	1.7	8.8	17.4	20.1	24.0	20.9	14.6	11.9
Non-current Assets	86.7	60.9	37.6	43.3	45.7	51.9	30.0	18.3	13.1	15.7	9.3
Property, Plant & Equipment	3.7	3.6	2.9	6.4	6.1	6.7	7.2	8.4	9.4	10.1	5.4
Intangible Assets	52.2	33.2	31.2	33.2	33.7	39.4	19.4	8.5	1.9	2.2	0.6
Total Liabilities	20.0	28.3	7.5	9.1	19.0	41.4	16.2	13.5	18.6	35.2	18.8
Current Liabilities	19.5	27.5	6.9	8.4	16.7	9.0	13.9	11.4	18.5	27.9	9.7
Non-current Liabilities	0.5	0.8	0.6	0.7	2.3	32.4	2.3	2.1	0.1	7.3	9.1
Total Equity	110.7	39.4	45.3	58.2	61.6	52.3	47.0	40.5	30.9	18.2	24.6
Share Capital	48.0	19.9	19.9	19.8	19.3	18.0	17.3	16.9	16.3	15.1	15.1
Retained Earnings	-41.7	-19.6	-12.6	-105.8	-90.1	-70.2	-62.6	-63.3	-65.9	-67.3	-59.5

Breakdown ₩ bn	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015
Cash from Operating Activities	-17.0	2.3	-6.0	-16.5	-0.5	7.5	—	—	—	—	—
Cash from Investing Activities	-38.6	-19.7	5.2	8.5	-12.4	-26.8	—	—	—	—	—
Cash from Financing Activities	74.4	19.2	-0.1	1.7	3.0	33.0	—	—	—	—	—
Net Change in Cash	18.7	1.8	-0.9	-6.5	-10.0	13.7	2.4	-1.7	-4.9	-2.2	9.7

Breakdown ₩ bn	2026 Q2	2026 Q1	2025 Q4	2025 Q3	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1
Total Revenue	0.5	0.3	1.9	0.6	0.3	0.7	0.4	0.5	9.2	5.0
Cost of Revenue	0.7	0.4	1.9	0.6	0.3	0.5	0.2	0.5	0.2	2.2
Gross Profit	-0.2	-0.1	0.1	-0.0	0.0	0.2	0.1	-0.0	9.0	2.8
Selling, General & Administrative	5.4	4.6	4.5	4.6	4.9	4.5	2.9	3.3	3.3	1.6
Operating Income	-5.5	-4.7	-4.4	-4.6	-4.8	-4.3	-2.8	-3.3	5.7	1.2
Finance Income	0.3	0.4	2.0	0.2	1.0	0.4	0.2	0.1	0.0	0.1
Finance Costs	1.9	0.6	0.6	0.2	0.8	1.1	1.0	0.9	0.4	0.1
Pretax Income	-7.6	-5.3	-4.7	-7.0	-4.3	-6.1	-4.6	-5.1	1.6	1.2
Income Tax Expense	1.8	0.0	0.0	-0.0	0.0	0.0	0.0	-0.0	-0.0	0.0
Net Income	-11.6	-5.3	-4.7	-7.0	-4.3	-6.1	-4.6	-5.1	1.6	1.2
Total Comprehensive Income	-11.5	-2.2	-4.9	-6.8	-4.4	-6.1	-4.3	-5.0	1.5	1.1

Breakdown ₩ bn	2026 Q2	2026 Q1	2025 Q4	2025 Q3	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1
Total Assets	131.3	129.1	130.7	116.6	119.8	142.4	67.7	71.0	76.0	53.7
Current Assets	43.8	40.0	44.0	36.0	39.2	82.1	6.8	9.1	15.4	16.2
Cash & Cash Equivalents	17.1	8.1	22.3	8.9	11.6	63.5	3.7	8.1	4.4	3.9
Inventories	0.8	1.2	1.1	2.2	1.7	1.7	1.1	0.4	0.6	0.6
Trade Receivables	0.7	0.5	2.5	0.6	1.6	1.7	1.6	0.4	10.2	5.4
Non-current Assets	87.5	89.1	86.7	80.7	80.6	60.3	60.9	61.9	60.6	37.6
Property, Plant & Equipment	4.5	3.3	3.7	4.0	4.2	4.3	3.6	2.6	2.7	2.8
Intangible Assets	52.2	52.2	52.2	52.2	52.2	33.2	33.2	33.2	31.2	31.2
Total Liabilities	28.0	17.1	20.0	6.3	5.4	24.9	28.3	27.2	27.3	7.3
Current Liabilities	18.5	16.7	19.5	5.6	4.7	24.1	27.5	26.4	26.6	6.7
Non-current Liabilities	9.5	0.5	0.5	0.7	0.7	0.8	0.8	0.8	0.7	0.6
Total Equity	103.3	112.0	110.7	110.3	114.5	117.5	39.4	43.7	48.8	46.4
Share Capital	48.3	48.3	48.0	48.0	24.0	24.0	19.9	19.9	19.9	19.9
Retained Earnings	-58.6	-47.0	-41.7	40.0	37.2	-25.7	-19.6	-14.9	-9.8	-11.4

Breakdown ₩ bn	2026 Q2	2026 Q1	2025 Q4	2025 Q3	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1
Cash from Operating Activities	-5.4	-2.1	-5.5	-3.5	-4.6	-3.4	-4.0	6.0	8.0	-7.8
Cash from Investing Activities	4.5	-12.0	4.3	0.9	-27.9	-15.8	-0.3	-2.4	-26.9	9.9
Cash from Financing Activities	9.8	-0.2	14.7	-0.1	-19.3	79.0	-0.2	-0.0	19.4	0.0
Net Change in Cash	9.0	-14.2	13.5	-2.7	-51.9	59.8	-4.4	3.6	0.6	2.1

Consolidated (CFS), from DART. 11 fiscal years and 10 quarters. Accounts matched on IFRS account_id, not Korean labels, so the same line holds across years where the Korean wording changed. Quarterly figures are three-month values: income quarters from DART's three-month column, cash-flow quarters differenced from DART's cumulative figures, and Q4 as annual minus nine-month cumulative.

048410 Growth

FY2025 ₩bn	Latest	1-yr	3-yr CAGR	5-yr CAGR	10-yr CAGR
Revenue	3.5	-76.6%	-23.5%	-22.4%	-21.7%
Operating income	-18.2	—	—	—	—
Net income	-22.1	—	—	—	—
EPS	₩-229	—	—	—	—
Operating cash flow	-17.0	—	—	—	—
Shareholders' equity	110.7	+180.8%	+23.9%	+16.2%	+16.2%

Compound annual growth from the DART annual statements on this page. n/m where either end of the period is a loss or missing. EPS uses today's share count for every year.

048410 Profitability

Ratio	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Gross margin	6.9%	78.8%	53.2%	34.2%	38.1%	52.5%
Operating margin	-516.3%	5.5%	-103.2%	-335.7%	-105.7%	-36.3%
Net margin	-629.1%	-46.0%	-152.9%	-201.3%	-217.0%	-66.0%
Return on equity	-29.5%	-16.4%	-28.0%	-26.4%	-35.2%	-16.6%
Return on assets	-22.3%	-11.5%	-24.1%	-21.4%	-23.0%	-10.5%
Operating cash flow / revenue	-484.7%	15.0%	-63.4%	-210.7%	-5.8%	60.0%

Margins divide by revenue for the same year. Return on equity and assets divide net income by the average of that year's and the prior year's balance, as DART reports them (consolidated, including minority interests).

Similar to 048410

Symbol	Last Price
268280Miwon Specialty Chemical	₩130,700 -1.3%
001570Kumyang Co., Ltd.	₩9,900 +0.0%
014820Dongwon Systems Corporation	₩21,700 -2.3%
006650Korea Petro Chemical IND	₩96,700 +0.3%
006380Capro Corporation	₩3,660 +0.0%
102710ENF Technology Co., Ltd.	₩41,950 +2.2%
002350Nexen Tire Corporation	₩6,080 +0.0%
002840Miwon Commercial Co., Ltd.	₩130,000 -1.1%
121600Advanced Nano Products Co., Ltd.	₩47,000 +0.1%
178920PI Advanced Materials Co., Ltd.	₩19,030 +0.8%

Compare all 43 in Chemicals

What a US investor should know

Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
Daily limitKorean stocks can move at most ±30% in a session before trading halts.
Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.